552331-67-6

Basic information

• Product Name: 6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine
• Synonyms: 6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine;6-fluoro-3-(4-pyridinyl)-1H-Pyrazolo[3,4-b]pyridine
• CAS NO: 552331-67-6
• Molecular Formula: C₁₁H₇FN₄
• Molecular Weight: 214
• Mol File: 552331-67-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine(552331-67-6)
• EPA Substance Registry System: 6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine(552331-67-6)

Safety Data

• Hazardous Substances Data: 552331-67-6(Hazardous Substances Data)

Usage

General Description

The chemical "6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine" is a heterocyclic compound with a pyrazolopyridine structure. It contains a fluoro group at the 6-position and a pyridin-4-yl group at the 3-position. 6-fluoro-3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine is used in pharmaceutical research and drug development, particularly in the study of potential treatments for various diseases and conditions. Its unique structure and properties make it of interest to medicinal chemists and researchers as a potential lead compound for the development of new therapeutic agents.

Upstream product

• 552331-65-4 (2,6-difluoropyridin-3-yl)(pyridin-4-yl)methanol 
• 1513-65-1 2,6-difluoro pyridine 
• 1692-15-5 4-pyridylboronic acid 
• 552331-66-5 (2,6-difluoropyridin-3-yl)(pyridin-4-yl)methanone 

Relevant articles and documents

PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF

The present invention relates to pyrazolyl-containing tricyclic derivative, a preparation method therefor and the use thereof. In particular, the present invention relates to a compound as shown in the general formula (I), a preparation method therefor and a pharmaceutical composition containing the compound, and the use thereof as a protease such as ERK (MAPK) inhibitor in the treatment of cancers, bone diseases, inflammatory diseases, immunological diseases, nervous system diseases, metabolic diseases, respiratory diseases and heart diseases, wherein the definition of each substituent in the general formula (1) is the same as defined in the description.

Kinase inhibitors

Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.